The ST3Gal-I Sialyltransferase Controls CD8+ T Lymphocyte Homeostasis by Modulating O-Glycan Biosynthesis  by Priatel, John J et al.
Immunity, Vol. 12, 273±283, March, 2000, Copyright ª 2000 by Cell Press
The ST3Gal-I Sialyltransferase Controls CD81
T Lymphocyte Homeostasis by Modulating
O-Glycan Biosynthesis
1 O-glycans in the thymus prior to peripheral emigration
appears as a conserved feature in the development of
T cells. Upon immune activation in the periphery, T cell
core 1 O-glycans become desialylated and core 2
O-glycans are induced with an increase in activity of a
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2Department of Biology entiation of activated effector CD81 T cells into viable
memory CD81 T cells occurs with a significant resialyla-3Department of Medicine
University of California, San Diego tion of core 1 O-glycans (Galvan et al., 1998).
The vertebrate genome encodes over a dozen sialyl-La Jolla, California 92093
4The Burnham Institute transferases that operate in the Golgi apparatus to mod-
ify various classes of glycans (Lowe and Marth, 1999).La Jolla, California 92037
They exhibit unique substrate specificities for various
glycans as well as different expression patterns during
ontogeny and among cell types (Paulson et al., 1989;Summary
Kitagawa and Paulson, 1994; Kono et al., 1997). For
example, the ST6Gal-I sialyltransferase is highly ex-T lymphocyte activation evokes distinct changes in
pressed in hematopoietic compartments and its sialyla-cell surface O-glycans. CD81 T cells undergo an elimi-
tion of N-glycans is essential for B lymphocyte immunenation of sialic acid on core 1 O-glycans and an induc-
function (Hennet et al., 1998). Among sialyltransferases,tion of core 2 O-glycans until either apoptotic death
ST3Gal-I exhibits unique specificity in vitro for the coreor differentiation into memory cells. We find that
1 O-glycan Galb1±3GalNAc (Kono et al., 1997), and ex-the ST3Gal-I sialyltransferase is required for core 1
pression of ST3Gal-I has been shown to be induced inO-glycan sialylation and its deficiency induces core 2
medullary thymocytes (Despont et al., 1975; Sasaki etO-glycan biosynthesis. Apoptosis ensues with the loss
al., 1982; Toporowicz and Reisner, 1986; Gillespie et al.,of peripheral CD81 T cells in the absence of immune
1992, 1993; Lee et al., 1993; Kono et al., 1997). Thesestimulation. Cell surface ligation of the ST3Gal-I sub-
data imply that the ST3Gal-I sialyltransferase is likelystrate CD43 recapitulates this phenotype by a caspase
involved in the varied PNA binding profiles observed3±independent mechanism. Control of core 1 O-glycan
among developing and activated T lymphocytes. An in-sialylation in T lymphocytes by ST3Gal-I comprises a
duced genetic absence of ST3Gal-I may therefore pre-homeostatic mechanism that eliminates CD81 T cells
clude the sialylation of core 1 O-glycans. Such a studyby apoptosis while facilitating the production of viable
could address whether this sialic acid modification isCD81 memory T cells.
important in thymocyte development or whether it plays
a role in the activation program among the peripheralIntroduction
lymphoid population. We have inactivated the gene en-
coding ST3Gal-I using Cre-loxP recombination bothPrecise changes in cell surface glycan structures have
systemically and somatically among T lymphocytes tobeen associated with lymphocyte maturation and acti-
study the biology of this posttranslational modificationvation (Raedler et al., 1981; Chervenak and Cohen, 1982;
and to address these hypotheses.Piller et al., 1988). Among the most commonly docu-
mented examples is the addition of a sialic acid to core
Results1 O-glycans during thymic T cell development among
vertebrates including lizards, chickens, mice, rats, sheep,
Inactivation of the ST3Gal-I Sialyltransferase Geneand humans (Reisner et al., 1976, 1979; Rose and Mal-
Increases Expression of Galb1±3GalNAc-Ser/Thrchiodi 1981; Kabir et al., 1983; Uni and Heller, 1991;
O-GlycansMansour et al., 1995). Cortical thymocytes express the
A genomic clone of the ST3Gal-I gene was used in con-Galb1±3GalNAc-Ser/Thr core 1 O-glycan at the cell sur-
structing a targeting vector that incorporated Cre/loxPface, the specific ligand of the plant lectin peanut agglu-
recombination (Figure 1A). The selected mutation de-tinin (PNA) (Pereira et al., 1976). At the time thymocytes
letes exon 2 and the majority of the large sialyl motiftransit to the medulla, this O-glycan is modified by
(Figure 1B, sequence not shown), essential for catalysisthe addition of sialic acid in a2±3 linkage, producing
(Datta and Paulson, 1995). Continued RNA productionthe trisaccharide Siaa2±3Galb1±3GalNAc, which is no
and splicing would result in a frame-shift and transla-longer a ligand for PNA. Acquisition of sialylated core
tional termination codon by fusion between exons 1
and 3. ES cell clones bearing either a deletion (D) or
5 To whom correspondence should be addressed (e-mail: jmarth@ conditional-null (F) allele (Figure 1C) were used to gener-
ucsd.edu).
ate mice homozygous for either allele. Mice lacking exon6 These authors contributed equally to this work.
2 sequences (D/D) in their genome (Figure 1D) were7Present Address: Department of Microbiology and Immunology,
University of British Columbia, Vancouver, Canada V6T 1Z3. obtained at Mendelian frequencies, developed normally
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Figure 1. ST3Gal-I Gene Mutagenesis Increases Cell Surface Levels of Unsialylated Core 1 O-Glycans
(A) Construction of the ST3Gal-I targeting vector for subsequent Cre-loxP recombination. LoxP sites are denoted as black arrowheads. ST3Gal-I
coding exons are numbered. Positions of PCR primers (small arrows) used for detecting homologous recombinants are also shown.
(B) Genomic structure of the ST3Gal-I gene is shown following homologous recombination F[tkneo] and subsequently following Cre recombina-
tion, the latter producing deleted (D) and conditional-mutant (F) alleles.
(C) These allelic structures were confirmed by Southern blotting of embryonic stem cells clones isolated following homologous recombination
(1G8) and from subsequent Cre expression producing deleted (1G8±1±3) or conditional-mutant (1G8±4) alleles.
(D) Mice bearing the D allele have lost exon 2 sequences of ST3Gal-I from the genome.
(E) The ability of PNA to delineate thymic cortical-medullary compartments is reduced in mice homozygous for the ST3Gal-I deletion (D/D),
as cells in the medulla exhibit increased PNA binding.
(F) Using the lectin MAL-II, reduced cell surface levels of a2±3-linked sialic acids are evident on CD41 and especially CD81 thymic T cells.
Background fluorescence is shown (dotted lines).
and were fertile. Additionally, they exhibited a normal- cell surface molecules CD3, CD4, CD8, CD44, CD69,
sized thymus including cortical and medullary compart- HSA, Ly-6C, and class I MHC (Figure 2A; data not
ments unaffected by histochemical analysis. Medullary shown). However, blood, spleen, and lymph nodes from
thymocytes in mice of the D/D genotype bound PNA ST3Gal-I-deficient mice were deficient in CD81 T cells
lectin at high levels indicating a deficiency of sialylation (Figure 2B). Approximately 10% of normal viable CD81
of the core 1 O-glycan Galb1±3GalNAc-Ser/Thr (Figure T cell numbers remained in mice 8±12 weeks of age.
1E). Using MAL-II lectin, specific for a2±3 sialic acid A smaller decrease in CD41 T cell numbers was also
linkages (Wang and Cummings, 1988), an almost com- apparent. No sequestration of T cells in other anatomic
plete loss of binding was observed among thymic CD81 compartments was noted (data not shown). Using the
T cells with a lessor reduction among thymic CD41 T TUNEL assay, an increase in apoptosis was evident in
cells (Figure 1F). the spleen (Figure 2C). The cell type(s) undergoing in-
creased apoptosis were found to be predominantly
CD81 T cells (Figure 2D). There was also a slight increasePeripheral CD81 T Lymphocyte Apoptosis and
in apoptotic CD41 T cells among both spleen and lymphCytotoxicity in Mice Deficient in ST3Gal-I
nodes; however, there was no evidence of increasedST3Gal-I deficiency did not influence thymocyte devel-
opment and normal expression was observed among CD81 or CD41 apoptosis in the thymus.
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Figure 2. Analyses of T Cell Development, Abundance, and Function Reveal an Apoptotic Loss of Peripheral Cytotoxic CD81 T Cells
(A) Thymocyte development appears unaltered among CD4 and CD8 thymocyte subsets.
(B) Loss of CD81 T cells is observed in the blood, lymph nodes, and spleen of ST3Gal-I-deficient mice.
(C) Using TUNEL, apoptotic nuclei (red) are increased 2- to 3-fold in the spleen.
(D) Using the apoptotic marker Annexin V, an increase in apoptosis occurs among peripheral CD81 T cells.
(E) CD81 peripheral T cells from ST3Gal-I-deficient mice are mostly of the memory phenotype, expressing both CD44 and Ly-6C. Most naive
cells are apoptotic, while memory cells show a less severe but significantly increased apoptotic phenotype in the absence of ST3Gal-I. The
absolute numbers of naive and memory CD81 T cells are reduced in the spleen (shown) and lymph nodes (data not shown) of ST3Gal-I-
deficient mice. A slight reduction in naive CD41 T cells (assessed by CD62L expression) was also observed. In (A), (D), and (E), percentages
of total populations within the defined gates are numerically indicated.
(F) Reduced cytotoxic T cell activity in the spleen is evident among ST3Gal-I-deficient mice inoculated with the P815 tumor cell line. Results
with the control MHC-matched EL-4 tumor cell are also plotted.
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Cytometric analyses of the peripheral lymphoid popu-
lations did not reveal changes in expression of activa-
tion-associated molecules such as class II MHC, HSA,
CD62L, and CD69. However, the level of CD44 was in-
creased among remaining peripheral ST3Gal-I-deficient
CD81 T cells. The majority of ST3Gal-I-deficient CD81
T cells were of the ªmemory phenotype,º with high ex-
pression levels of both CD44 and Ly-6C (Figure 2E). This
contrasts with results from 8- to 12-week-old wild-type
littermates, also housed under specific-pathogen-free
conditions where the majority of CD81 T cells are of
the naive (CD44lowLy-6Clow) phenotype. The majority of
remaining naive CD81 T cells were apoptotic, and an
increase in memory cell apoptosis was also observed.
Absolute numbers of naive CD81 T cells were greatly
reduced along with a significant reduction in the number
of memory CD81 T cells in ST3Gal-I-deficient mice.
These CD44highLy6ChighCD81 T cells exhibited a lower
threshold of activation in vitro upon TCR cross-linking
as expected of CD81 memory T cells (data not shown).
A reduction in the ratio of naive to memory T cells, albeit
less severe, was also observed among CD41 T cells in
ST3Gal-I-deficient mice.
To determine whether diminished levels of CD81 T
cells in ST3Gal-I-deficient mice resulted in immunologic
consequences, littermates bearing wild-type or ST3Gal-
I-different genotypes were inoculated with the MHC-
mismatched tumor cell line P815. Cytotoxic T cell activ-
ity present in the spleen of ST3Gal-I-deficient mice at
10 days postinoculation was reduced at various ef-
fector:target cell ratios (Figure 2F). When normalizing
the response to CD81 T cell numbers, cytotoxicity was
not diminished, implying that lack of ST3Gal-I does not
impede cytotoxic effector function.
Conditional Mutagenesis Reveals that ST3Gal-I
Deficiency in T Cells Causes Apoptosis
The apoptotic death of CD81 T cells in mice bearing an
inherited deletion in the ST3Gal-I gene could result from
ST3Gal-I deficiency among T cells or from loss of
Figure 3. T Cell±Specific Mutagenesis by Cre-loxP Recombination
ST3Gal-I from another cell type that otherwise maintains Reveals that the Apoptosis of CD81 T Lymphocytes Is Due to Loss
the viability of peripheral CD81 T cells. To distinguish of ST3Gal-I Function in T Cells
between these possibilities, we inactivated ST3Gal-I (A) Southern blot analysis of ST3Gal-I alleles among germline homo-
function specifically in T cells using Cre-loxP recombina- zygous deleted (D) and conditional (F) alleles (left) compared with
alleles in somatic cells of mice homozygous for the F allele andtion. Mice bearing the conditional ST3Gal-I mutation (F)
bearing a germline lck-Cre transgene (Hennet et al., 1995).were bred to acquire the lck-Cre transgene in which Cre
(B) The majority of CD41 or CD81 thymic T cells undergo recombina-expression is restricted to thymocytes (Hennet et al.,
tion and exhibit increased PNA binding in ST3Gal-IF/F mice bearing
1995). Mice that were homozygous for the conditional lck-Cre.
mutation (F/F) and hemizygous for the lck-Cre transgene (C) A deficiency of CD81 T cells occurs in the periphery of mice
were analyzed for ST3Gal-I allelic structure (Figure 3A). undergoing a T cell±specific loss of ST3Gal-I function. Similar results
were obtained among the spleen (shown), lymph nodes, and periph-In most animals, 90% of thymocytes had undergone Cre
eral blood.recombination at both alleles, resulting in a significant
(D) Selection in vivo against peripheral CD81 T cells lacking ST3Gal-I.proportion of cells homozygous for the deletion (D/D
Viable splenic CD81 T cells (Annexin V2) from ST3Gal-IF/F mice bear-
genotype). As a result, the expected increase in PNA ing the lck-Cre transgene were mostly PNAlow compared to their
binding on the cell surface occurred among the majority thymic precursors in (B). A less robust selection against PNAhighCD41
of medullary single-positive thymocytes (Figure 3B). T cells is observed. The data shown are representative of results
obtained in six different comparisons.Cells were present in which Cre recombination did not
occur or had not acted on both F alleles and thus led
to some CD41 or CD81 thymic T cells that remained
PNAlow. transgene (Figure 3C). As some thymocytes did not un-
dergo Cre recombination, peripheral T cell populationsA significant reduction in peripheral CD81 T cell num-
bers was noted in mice homozygous for the loxP-flanked exhibited a binary PNA binding profile. Most viable pe-
ripheral CD81 T cells were PNAlow, while the inverseST3Gal-I allele and in the presence of the lck-Cre
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Figure 4. ST3Gal-I Modifies a Subset of T Cell Glycoproteins and Inhibits the Formation of Core 2 O-Glycans
(A) ST3Gal-I glycoprotein substrates in T cell membranes identified by PNA blotting, with specificity as shown in the presence of free galactose
(left, upper and lower panels). PNA binding to three glycoproteins was found to be altered.
(B) CD45 exhibited increased PNA binding. CD8 was also similarly affected (indicated; data not shown).
(C) CD43 exhibited a change in molecular weight using the panspecific CD43 antibody H18. This was due to the presence of core 2 O-glycans
on CD43 as determined using the glycoform-specific CD43 antibody 1B11. Unsialylated core 1 O-glycans (PNA binding) were found on CD43
in the presence of core 2 O-glycans.
(D) Oligosaccharide analysis was carried out on splenocytes (shown) and thymocytes of wild-type and ST3Gal-I-deficient mice. Radiolabeled
O-linked oligosaccharides were subjected to Bio-Gel P-4 gel filtration before (upper panels) and after desialylation (lower panels). Peaks 1,
2, 3, 4, 5, and 6 indicate the elution positions of disialylated forms of Galb1±3(Galb1±4GlcNAcb1±6)GalNAc (peak 1) and Galb1±3GalNAc (peak
2) as well as monosialylated forms of Galb1±3(Galb1±4GlcNAcb1±6)GalNAc and Galb1±3GalNAc (peak 3), Galb1±3(Galb1±4GlcNAcb1±6)GalNAc
(peak 4), free sialic acid (peak 5), and Galb1±3GalNAc (peak 6).
(E) Core 2 GlcNAcT activity was unaltered in the spleen (shown) and thymus and tissues from mice lacking ST3Gal-I function. Experiments
were carried out in duplicates and standard deviation is shown.
was true for peripheral CD41 T cells (Figure 3D). This binding of CD8-deficient T cells was reduced (Figure
4B; data not shown). Unexpectedly, CD43 mobility byindicates a strong selection in vivo for peripheral CD81
T cells that have maintained ST3Gal-I function, while SDS-PAGE was reduced in the absence of ST3Gal-I and
migrated with a molecular weight of 130 kDa instead ofthese data together provide a cell type on which to focus
further mechanistic studies. Further studies of ST3Gal-I 115 kDa (Figure 4C). Moreover, reactivity of the CD43
antibody 1B11, which is specific for CD43 bearing coredeficiency were accomplished with the systemic-null
mice, as both mutations exhibited identical phenotypes, 2 O-glycans (Ellies et al., 1996), was greatly increased
in the absence of ST3Gal-I. This 130 kDa glycoformwhile the conditional mutation can lead to chimeric T
cells populations. of CD43 also bound PNA, indicating the presence of
unsialylated core 1 O-glycans.
The expression of core 2 O-glycans was furtherST3Gal-I Competes to Inhibit Core 2 O-Glycan
Formation on Substrate Glycoproteins confirmed by biochemical analyses of thymocyte and
splenocyte O-glycan fractions. As would be expectedST3Gal-I substrates were identified among T cells by
PNA lectin blotting and immunoprecipitation (Figure 4A). in the absence of ST3Gal-I, a significant reduction in
disialyl oligosaccharides was evident (Figure 4D, upperCore 1 O-glycans on CD45 exhibited a marked increase
in PNA binding in the absence of ST3Gal-I, while PNA panels, peaks 1 and 2), while monosialylated species
Immunity
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Figure 5. Aggregation of the Altered CD43 Glycoform Induces CD81 T Cell Apoptosis by a Caspase 3-Independent Mechanism, and Apoptosis
Is Inhibited by T Cell Activation
(A) Thymic (shown) or splenic T cells were subjected to antibody- or lectin-induced O-glycan aggregation. The percent of T cells undergoing
apoptosis was determined at indicated times. CD43 aggregation using the 1B11 antibody induced CD81 T cell apoptosis, as did treatment
with PNA lectin (left panel). TCR activation by anti-CD3 and IL-2 inhibited apoptosis in the presence of 1B11 or PNA. No apoptotic response
was observed among CD41 T cells (middle panel). CD81 T cells express the CD43 glycoform bearing core 2 O-glycans at 5-fold higher levels
than CD41 cells (right panel).
(B) 1B11-induced CD81 T cell apoptosis is inhibited by the panspecific caspase inhibitor Boc-Asp-OMe-FMK (Boc-D) and the caspase inhibitor
ZVAD. Caspase inhibitors (200 mM of each FMK derivative) were applied prior to 1B11, and apoptosis was assessed after 24 hr. No reduction
in CD43-induced apoptosis was observed in the presence of other caspase inhibitors, a granzyme B inhibitor, cyclohexamide, MnTBAP,
genistein, or herbamycin.
(C) 1B11-induced CD81 T cell apoptosis does not involve caspase 3. Caspase 3 activity induced by 1B11 is completely abolished by the
caspase 3 inhibitor DEVD (left panel), while apoptosis induced by 1B11 is unaffected (right panel). In experiments above, results with mice
homozygous for wild-type (white boxes) or deleted (black boxes) ST3Gal-I genotypes are presented.
were increased (peak 3). Additionally, following desialy- also capable of specifically inducing CD81 T cell apo-
ptosis. However, activation of CD81 T cells by anti-CD3lation, the ST3Gal-I-deficient samples contained mostly
Galb1±3(Galb1±4GlcNAcb1±6)GalNAc (lower panels, peak and interleukin-2 (IL-2) inhibited the ability of CD43 ag-
gregation or PNA treatment to induce apoptosis. No4). The molar ratio of core 2 O-glycans (lower panels,
effect was observed among CD41 T cells subjected topeak 4) to core 1 O-glycans (Galb1±3GalNAc, peak 6)
identical stimuli (Figure 5A, middle panel). Levels of corewas dramatically increased from 1.5 to 4.7 in the ab-
2±reactive CD43, assessed by 1B11 antibody, were ap-sence of ST3Gal-I. This increase in core 2 O-glycans
proximately 5-fold higher in normal and ST3Gal-I-defi-was not due to an increase in core 2 N-acetylglucosami-
cient CD81 T cells compared to CD41 T cells (Figurenyltransferase (core 2 GlcNAcT) activity (Figure 4E).
5A, right panel; data not shown). The induction of CD43These findings reveal that ST3Gal-I sialylation of core 1
glycoprotein aggregation in vitro appears to recapitulateO-glycans actively inhibits core 2 O-glycan biosynthesis
the phenotype and may thus reflect an endogenousin vivo.
mechanism operating similarly in vivo.
CD81 T Cell Apoptosis Is Induced by CD43 Aggregation CD81 T Cell Apoptosis Requires Caspase Activation
and Inhibited by T Cell Activation CD81 T cells incubated with the 1B11 antibody were
Since glycans may modulate protein±protein interac- analyzed in the presence of various caspase inhibitors,
tions, we determined whether induced glycoprotein ag- a granzyme B inhibitor, or other compounds known to
gregation could affect the apoptotic phenotype of CD81 modify T cell apoptosis. The panspecific caspase inhibi-
T cells. Antibody-induced cell surface cross-linking of tor Boc-Asp-OMe-FMK (Boc-D) and the caspase 1 inhib-
CD43 bearing core 2 O-glycans was performed using itor ZVAD blocked CD43-induced apoptosis (Figure 5B).
the 1B11 antibody. This was sufficient to generate apo- However, other compounds including the caspase 3 in-
ptosis, specifically among ST3Gal-I-deficient CD81 T hibitor DEVD as well as a granzyme B inhibitor did not
cells (Figure 5A, left panel), whether T cells were derived attenuate apoptosis. Neither did the superoxide dismu-
from the thymus or periphery. This result was not ob- tase mimetic MnTBAP, the protein synthesis inhibitor
served when CD8 or CD45 glycoproteins were similarly cyclohexamide, or the tyrosine kinase inhibitors herba-
mycin and genistein.aggregated. The multivalent tetrameric PNA lectin was
O-Glycan Sialylation in CD81 T Cell Homeostasis
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Figure 6. Immune Response and Memory
Cell Differentiation of CD81 T Cells Induces
Changes in O-Glycan Biosynthesis Involving
ST3Gal-I Function
(A) Within 72 hr following naive CD81 T cell
activation, cell surface O-glycans are modi-
fied from PNAlow1B11low to PNAhigh 1B11high.
Memory CD81 T cells (CD44high and Ly-6Chigh)
normally undergo a return to a naive-like
O-glycan state in which core 1 O-glycans are
mostly sialylated and core 2 O-glycans are
no longer present on CD43.
(B) These responses may occur by altering a
balance between the action of ST3Gal-I and
core 2 GlcNAcT glycosyltransferases, which
can compete for the same O-glycans. In the
genetic absence of ST3Gal-I, core 2 O-gly-
cans are generated and CD81 T cells become
PNAhigh and 1B11high.
We confirmed that caspase 3 was not involved by among peripheral CD81 T cells and in the absence of
immune stimulation. Our findings provide a mechanismusing an antibody specific for the activated form, while
simultaneously monitoring Annexin V reactivity induced by which the immune system may normally regulate levels
of peripheral CD81 T cells.by CD43 in the presence or absence of DEVD. From 3
to 6 hr following CD43 ligation, caspase 3 activation is
induced among ST3Gal-I-deficient CD81 T cells, and CD81 T Cell O-Glycan Structures in Activation
and Memorythis can be completely abolished by DEVD (Figure 5C,
left panel). However, inhibition of caspase 3 activation The activation of primary CD81 T cells by antigen or
anti-CD3 stimulation invariably alters O-glycan biosyn-does not attenuate apoptosis induced by the 1B11-reac-
tive glycoform of CD43 (Figure 5C, right panel). thesis in a precise manner. Core 1 O-glycans on medul-
lary and peripheral CD81 T cells are highly sialylated
prior to activation and become desialylated within 48±72Discussion
hr, yielding a PNAhigh phenotype (Figure 6A, left panel).
In addition, core 2 O-glycans on CD43 are induced in aT lymphocyte apoptosis occurs on a large scale in the
aftermath of a successful immune response. This resets similar time course concurrent with a significant in-
crease of core 2 GlcNAcT activity, thereby leading tolymphocyte numbers by a mechanism that removes the
vast majority of previously activated lymphocytes while the CD43 1B11high phenotype (Piller et al., 1988; Figure
6A, left panel). This PNAhigh1B11high O-glycan phenotypegenerating a new population of memory T cells. Suscep-
tibility to apoptosis is acquired following antigen recep- on activated CD81 T cells is not maintained, however,
and viable memory CD81 T cells have downregulatedtor activation by mechanisms that presently are not fully
understood but appear to differ among CD41 and CD81 this response to express core 1 O-glycans with in-
creased sialylation (PNAint.), while core 2 O-glycans onT cell subtypes (Thompson, 1999). What regulates the
enormous reduction of activated and effector CD81 T CD43 are no longer induced (1B11low) (Figure 6A, right
panel). These observations indicate that glycosyla-cells following an immune response is considered un-
known. Fas/FasL or tumor necrosis factor family mem- tion can be considered a dynamic process, like other
posttranslational modifications, and suggest that modu-bers are probably not involved in this process (Goldrath
and Bevan, 1999). At the cell surface, T cells destined for lating O-glycan structure may regulate glycoprotein
function.apoptosis show increased levels of phosphatidylserine
(Martin et al., 1995), although this is in response to an
initial apoptotic stimulus. The O-glycan structural ST3Gal-I Sialyltransferase Function in O-Glycan
Biosynthesis and CD81 T Cell Apoptosischanges we have studied precede phosphatidylserine
expression as they first occur upon CD81 T cell activa- ST3Gal-I activity on core 1 O-glycans is essential for
naive CD81 T cell viability. In the absence of ST3Gal-I,tion but appear to play a role in apoptosis specifically
Immunity
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Figure 7. The Relationship of O-Glycan Struc-
ture and ST3Gal-I Function in CD81 T Cell
Activation, Apoptosis, and the Production of
Viable CD81 T Cell Memory
ST3Gal-I induction in medullary thymocytes
generates the PNAlow1B11low phenotype es-
sential in preventing the premature apoptosis
of peripheral CD81 T cells. Immune stimula-
tion leads to an ªactivatedº O-glycan pheno-
type (PNAhigh and 1B11high). This may occur by
(1) induction of a core 1 O-glycan sialidase,
reduction in ST3Gal-I activity, or induction of
core 2 GlcNAcT activity. Upon depletion of
the immune stimulus, PNAhigh1B11highCD81 T
cells either undergo apoptosis or differentiate
in response to unknown signals (asterisk) into
viable memory cells in which core 1 O-gly-
cans are resialylated and core 2 O-glycans
are down-regulated, forming the PNAint. and
1B11low memory O-glycan phenotype. This may
occur by (2) attenuation of a core 1 O-glycan sialidase, induction of ST3Gal-I, or reduction in core 2 GlcNAcT activity. A genetic deficiency
of ST3Gal-I induces the PNAhigh1B11high O-glycan phenotype on naive CD81 T cells. Our data indicate that unless such CD81 T cells receive
an immune stimulus, they become apoptotic, leading to loss of naive CD81 T cells and increased apoptosis among CD81 memory T cells.
the naive CD81 T cell population is vastly reduced, and cell activation, apoptosis, and memory cell formation,
and the participation of O-glycans regulated by ST3Gal-Ithose remaining are virtually all apoptotic. ST3Gal-I
function is also essential for the emergence of normal (Figure 7). While we find that PNAhighCD81 T lympho-
cytes in wild-type mice are either apoptotic or activatedlevels of CD81 memory T cells, perhaps as their naive
precursors are vastly reduced in cell numbers. In addi- (data not shown), it remains to be established whether
an inability to desialylate core 1 O-glycans or inducetion, while wild-type CD81 memory T cells are PNAint. and
the majority do not bind Annexin V, ST3Gal-I-deficient core 2 O-glycans would alter the apoptotic reduction in
CD81 T cell numbers following an immune response.CD81 memory T cells are of the PNAhigh and 1B11high
phenotype, and most have become apoptotic.
ST3Gal-I sialylation of the Galb1±3GalNAc-Ser/Thr On the Mechanism of ST3Gal-I Function
T cell glycoprotein substrates of ST3Gal-I are few in vivocore 1 O-glycan has been reported to inhibit the ability
of core 2 GlcNAcT to act in vitro (Schachter and Brock- and include CD8, as previously indicated (Casabo et al.
1994; Wu et al., 1996). We find that CD43 and CD45 arehausen, 1989). This competition was not expected to
occur in vivo since sialyltransferases have been local- also ST3Gal-I substrates in vivo. However, ligation of
CD43 molecules bearing PNAhigh1B11high O-glycans spe-ized to the trans Golgi and are therefore considered to
act distally to glycosyltransferases found in cis and medial cifically induced CD81 T cell apoptosis. This response
appeared caspase dependent. Although caspase 3 acti-Golgi compartments such as core 2 GlcNAcT (Skiron-
cosky et al., 1997). ST3Gal-I deficiency in T cells results vation was observed, this cell response was not in-
volved. No change in Fas expression was observed inin core 2 O-glycan biosynthesis on CD43 without an
increase in core 2 GlcNAcT activity, indicating that the ST3Gal-I-deficient mice, and anti-Fas (CD95) antibody
treatment did not enhance apoptosis (data not shown).ST3Gal-I and core 2 GlcNAcT glycosyltransferases nor-
mally compete for the same O-glycan substrate(s) in the Neither did the addition of tumor necrosis factor (TNF),
neutralizing antibodies to TNF, or TNF receptor antibod-Golgi (Figure 6B). ST3Gal-I activity in naive CD81 T cells
restricts O-glycan biosynthesis by disallowing formation ies to p55 and p75 (data not shown). Intracellular apo-
ptotic responses appear to commonly involve caspaseof the PNAhigh1B11high phenotype found on activated
CD81 T cells. These activated cells bearing this O-glycan activation in a proteolytic cascade (reviewed in Los et
al., 1999) (Adams and Cory, 1998; Ashkenazi and Dixit,profile are not maintained and are thus destined for
either apoptosis or differentiation into PNAint.1B11low 1998). Caspase activation can also occur upon the cyto-
solic release of mitochondrial cytochrome c (Li et al.,memory cells.
The presence of ST3Gal-I-deficient memory CD81 T 1997), and another route involves reactive oxygen spe-
cies (Hildeman et al., 1999). CD43 has been reported tocells, fewer and more apoptotic than normal, indicates
that O-glycan downregulation to a PNAint.1B11low pheno- participate in human T cell apoptosis (Brown et al.,
1996), however, the mechanism is unresolved and thetype contributes to the viability of CD81 memory T cells.
With immune stimulation blocking apoptosis, produc- intracellular domain of CD43 lacks defined death domain
sequences known to initiate caspase activation cas-tion of ST3Gal-I-deficient CD81 memory T cells may
occur in vivo upon naive T cell activation shortly after cades. CD43 seems to play distinct roles in different
settings, while increased T cell activation responses andemigration from the thymus but prior to receiving the
apoptotic stimulus. In this regard, a significant rebound cytotoxic activity have been reported in CD43-deficient
mice (Manjunath et al., 1995).of CD81 T cell numbers was noted in ST3Gal-I-deficient
mice by day 10 in the periphery following inoculation O-glycans on both CD41 and CD81 T cells are sialy-
lated by ST3Gal-I, and yet only CD81 T cells are predomi-with the P815 tumor cell line. These observations to-
gether indicate a close relationship involving CD81 T nantly apoptotic in the absence of ST3Gal-I. This may
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be due to the increased level of CD43 normally found on vides a homeostatic mechanism regulating CD81 T cell
CD81 T cells. Nevertheless, an essential role for ST3Gal-I apoptosis and promotes the formation of viable CD81
among CD41 T cells is not evident, and a much smaller T cell memory.
fraction lacking ST3Gal-I underwent apoptosis. This
Experimental Proceduressupports the view that most CD41 T cells undergo apo-
ptosis by a mechanism distinct from that of CD81 T cells
ST3Gal-I Mutagenesisand not modulated by ST3Gal-I.
The porcine ST3Gal-I cDNA was used to screen a genomic 129SV/J
Loss of ST3Gal-I has no affect on thymocyte develop- DNA library in bacteriophage (Stratagene). A clone bearing three
ment or viability. The lack of significant apoptosis in coding exons (GenBank accession AF214028, AF214029, and
situ among medullary thymocytes lacking ST3Gal-I may AF214030) was used to construct a targeting vector depicted in
Figure 2A. The vector was electroporated into R1 ES cells (Nagy etindicate that the endogenous apoptotic stimulus is re-
al., 1993). ES cell clones were selected in the presence of 150 mg/mLstricted to peripheral compartments. This stimulus may
of bioactive G418 (Life Technologies) and screened by polymeraseconsist of a multivalent lectin that, like PNA or 1B11,
chain reaction and by Southern blotting (Figure 2; Orban et al.,acts to aggregate CD43 and may either be soluble or
1992). Transient Cre expression was delivered by electroporation
on a particular cell surface. Indeed, a family of galectins in targeted ES clones 1G8 (Figure 2) and 1B11 (data not shown).
has been found that bind to galactose residues on glyco- Following ganciclovir selection, subclones carrying either the
proteins (Cooper and Barondes, 1999) and galectin-1 ST3Gal-ID or ST3Gal-IF alleles were derived from the independent
parental ES cell clones (1G8 and 1B11). Chimeric mice were gener-has been suggested to bind CD43 and induce T cell
ated by blastocyst injection and mutant ST3Gal-I loci were indepen-apoptosis (Baum et al., 1995). However, in our studies
dently bred into the C57BL/6 strain. All studies were performed onexogenous galectin-1 did not have an effect (data not
mice maintained at least five generations in the C57BL/6 back-
shown). While macrophages express a lectin that binds ground.
desialylated core 1 O-glycans (Sato et al., 1992), they
did not induce apoptosis in coculture with CD81 ST3Gal- Oligosaccharide Analysis and Glycosyltransferase Assays
Splenocytes and thymocytes were metabolically labeled withI-deficient T cells (data not shown) nor did splenic den-
[3H]glucosamine (50 mCi/ml) for 20 hr and analyzed by describeddritic cells in coculture or following application of mouse
procedures (Hiraoka et al., 1999). O-linked oligosaccharides isolatedserum (data not shown). Finally, NK cell depletion in vivo
after alkaline-borohydride treatment were analyzed by Bio-Gel P-4by administration of the NK1.1 antibody did not result in gel filtration before and after desialylation. Core 2 GlcNAcT activity
the rescue of CD81 T cell numbers in ST3Gal-I-deficient was assayed using Galb1±3GalNAca1-p-nitrophenol as an acceptor
mice (not shown). according to described procedures (Ellies et al., 1998).
Alternatively, an autocrine mechanism may be in-
Flow Cytometryduced among PNAhigh1B11high CD81 T cells upon immune
Peripheral blood mononuclear cells were isolated by a density gradi-stimulus depletion and in the absence of signals leading
ent using Nycoprep. Single-cell suspensions from spleen, lymphto memory cell differentiation. This might reflect a ten-
node, or thymus were subjected to RBC lysis by ammonium chloride.
dency of the 1B111CD43 glycoform to form aggregates Cell labeling was carried out in 100 mL with 500,000 cells. All incuba-
of proteins that together initiate an apoptotic signal from tions were done in FACS buffer [2% FCS in PBS] on ice for 10 min.
the cell surface. An autocrine apoptotic mechanism ap- Data was acquired using a FACScan and analyzed by Cell Quest
(Becton Dickinson). PNA-FITC and biotinylated-MAL-II (Vector Lab-pears to be operating among various hybridomas and
oratories) were used at 100 ng/ml and 500 ng/ml, respectively. Anti-immortalized cell lines (Brunner et al., 1995; Dhein et al.,
mouse CD8-Tricolor was used (Caltag). Annexin V-FITC (Phar-1995; Ju et al., 1995). Moreover, it was not possible to
Mingen) was incubated for 15 min at room temperature in HEPESenhance the rate of apoptosis in response to 1B11 or
with 140 mM NaCl containing 2.5 mM Ca21. Other antibody reagents
PNA among wild-type CD81 T cells following activation recognized CD4, CD44, CD62L, HSA (CD24), CD3, Ly-6C, CD45RB,
and upon immune stimulus depletion (data not shown). CD43, and CD69 (PharMingen).
The selective physiologic function of the ST3Gal-I si-
T Cell Isolation, Activation, and Glycoprotein Analysisalyltransferase reveals a cell type specificity not uncom-
T cells were analyzed as a population from the thymus or spleen ormon among studies of genetically imposed alterations
following purification of peripheral CD41 and CD81 T cells using theon the mouse cell surface glycan repertoire (Maly et al.,
MiniMACS system (Miltenyi). For the latter, cells were resuspended1996; Chui et al., 1997; Ellies et al., 1998; Hennet et in 90 ml of PBS containing 0.5% BSA and 5 mM EDTA per 107 cells;
al., 1998). This may involve cell type±specific glycosyl- 10 ml of either anti-CD4 or anti-CD8 and anti-B220 microbeads were
transferase expression patterns, lectin molecules that added per 107 cells and incubated for 15 min at 88C. Cells were
recognize specific glycoproteins, and the production of separated from free microbeads by centrifugation, resuspended in
500 ml of buffer, and applied to the column and washed three timescertain glycoprotein conformations that promote aggre-
with 500 ml of buffer. Cells were eluted and judged to be over 90%gation. The reversible nature of glycosylation adds fur-
enriched by flow cytometry prior to culturing in complete DMEMther complexity. The decreased sialylation observed
containing 10% fetal calf serum, 0.1 mM 2-mercaptoethanol, and 2
upon CD81 T cell activation and its subsequent recovery mM L-glutamine. T cells were activated either with immobilized anti-
on memory cells may occur by regulation of an endoge- CD3 (2 mg/ml) or with anti-CD3 and IL-2 (Genzyme). Proliferation
nous sialidase (Galvan et al., 1998), perhaps related to was measured by [3H]thymidine incorporation (2.5 mCi per well) dur-
the Neu-1 sialidase found within the MHC locus (Peters ing the last 12 hr of the assay period. Antibodies to CD45 (131; Chui
et al., 1994), panspecific CD43 (H18; Jones et al., 1994), and CD43et al., 1981; Figueroa et al., 1982). Why the ST3Gal-I
bearing core 2 O-glycans (1B11; Ellies et al., 1996) were used asgene has been highly conserved in vertebrate radiation
indicated.is suggested by our findings. An inherited deficiency of
ST3Gal-I reduces cytotoxic T cell numbers and may Cytotoxic T Cell Activity
therefore attenuate resistance to pathogens and tumori- P815, a mastocytoma cell line from DBA/2 (H-2d), was maintained
genic lesions. In normal physiology, the highly selective in ascitic fluid in adult female DBA/2 mice by weekly passage. The
EL-4, a lymphoma line from C57Bl/6 (H-2b), was maintained in tissuemodification of O-glycan structures by ST3Gal-I pro-
Immunity
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culture. Media consisted of RPMI-1640, 10% heat-inactivated FBS, was funded by the National Institutes of Health grant P01HL 57345
(J. D. M.) and National Cancer Institute grant R37CA33000 (M. F.).1 mM glutamine, 1 mM sodium pyruvate, nonessential amino acids,
100 mg/ml pen/strep, 50 mM 2-ME. Mice were inoculated with 2 3 J. D. M. is an Investigator of the Howard Hughes Medical Institute.
106 P815 cells at day 1 and sacrificed on day 10. Mesenteric lymph
nodes (MLN), spleen, and peritoneal exudate cells (PEC) were har-
Received January 6, 2000; revised February 23, 2000.vested. Following RBC lysis, cells were resuspended in media. The
lymphocytes from the PEC were purified by plate-adherence in me-
dia for 1 hr at 378C and passaged over nylon-wool. Effector cells
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